Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study.

"CONFLICTS OF INTEREST The authors declare no competing financial interests in relation to the present study. Tove‐Christina C. Kristensen received travel grant from AbbVie (2021). Tarec C. El‐Galaly was previously employed by Roche Ltd (Basel) (2019–2021) and has received a speaker fee from Abbvie (2021) and received research funding from the Danish Cancer Society (not related to this study). Lasse H. Jakobsen received honoraria from and Roche (2021). The other authors have no conflicts of interests to disclose."

"Our profound gratitude to everyone who has participated in forming and collecting data for The Danish Acute Leukaemia Registry (DNLR) and The Danish Clinical Quality Program—National Clinical Registries (RKKP) for providing and governing the data. Financial support for this study was provided by the Danish Cancer Society (Grant R94‐A5768‐B2403) (for Marianne T. Severinsen)."